This Week in Policy and Medicine — March 2, 2025

0 179

Welcome to this week’s roundup on Policy and Medicine. Catch all episodes of “This Week in Policy and Medicine” on Spotify and your favorite podcast platform for more in-depth discussions.

President Trump Signs Executive Order to Boost Healthcare Price Transparency

In a significant move towards enhancing healthcare price transparency, President Trump has signed a new executive order. The initiative aims to provide patients with clearer insights into the costs of healthcare services before they receive care. Read the full story here.

Texas Hospital CEO Sentenced to Three Years in Prison for Anti-Kickback Violations

A major legal development has occurred as a Texas hospital CEO has been sentenced to three years in prison due to anti-kickback statute violations. This sentencing marks a notable enforcement of federal healthcare fraud laws. Details on the case can be found here.

Ohio Supreme Court Rules on Public Nuisance Claims in Opioid Litigation

The Ohio Supreme Court has issued a ruling on public nuisance claims related to opioid litigation, setting a precedent that could impact future cases across the country. For an in-depth analysis, click here.

DOJ Announces Potential $100 Million Settlement Over Alleged Medicare Advantage Upcoding

The Department of Justice has announced a potential settlement regarding alleged Medicare Advantage upcoding by a major healthcare provider. The settlement amount could reach up to $100 million. More information is available here.

FDA Releases Draft Guidance on the Accelerated Approval Process

The FDA has released new draft guidance aimed at streamlining the accelerated approval process for drugs and therapies, potentially speeding up the time it takes to bring new treatments to market. Read the draft guidance here.

Listen to Our Podcast

For more in-depth analysis and expert commentary on these stories, tune in to “This Week in Policy and Medicine” on Spotify or your favorite podcast platforms.

Leave A Reply

Your email address will not be published.